CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
26 hedge funds and large institutions have $4.22M invested in COSCIENS Biopharma Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
60% less capital invested
Capital invested by funds: $10.6M → $4.22M (-$6.38M)
Holders
26
Holding in Top 10
–
Calls
$1.17M
Puts
$347K
Top Buyers
| 1 | +$135K | |
| 2 | +$70K | |
| 3 | +$45.5K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$38K |
| 5 |
Two Sigma Advisers
New York
|
+$35K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$795K | |
| 3 | -$777K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$315K |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$296K |